放疗过程中肿瘤乏氧的纵向PET显像
本文综述了肿瘤乏氧的检测技术,指出只有PET被充分验证可用于临床乏氧检测。综述聚焦头颈部癌患者,汇总了使用乏氧PET示踪剂(如FMISO等)评估放疗全程中全肿瘤及亚区域乏氧行为的研究,关注乏氧区域在成像至治疗间及放疗过程中的稳定性。
要点
- 乏氧PET是唯一被充分验证可用于临床乏氧检测的显像方式。
- FMISO是最常用的乏氧PET示踪剂,另有FAZA、FETNIM、EF5、HX4等。
- 综述聚焦头颈部癌患者放疗全程中全肿瘤及亚区域乏氧行为。
核心结论
- 综述旨在描述放疗过程中全肿瘤及亚区域肿瘤乏氧的行为,重点关注头颈部癌患者。
研究设计与样本
- 综述,聚焦头颈部癌患者,汇总使用乏氧PET示踪剂评估放疗全程中全肿瘤及亚区域乏氧行为的研究。
主要发现
- 乏氧是实体恶性肿瘤(如头颈部癌)中的常见现象,乏氧细胞对治疗更抵抗,是预后不良的指标。
- 在影像方法中,只有PET被充分验证可用于临床乏氧检测。
- 乏氧PET示踪剂包括18F-氟米索硝唑(FMISO,最常用)、18F-氟阿霉素阿拉伯糖苷(FAZA)、18F-氟赤硝基咪唑(FETNIM)、18F-2-硝基咪唑五氟丙基乙酰胺(EF5)和18F-氟他硝唑(HX4)。
- 技术发展使得增加肿瘤亚区域(如乏氧区域)放疗剂量成为可能,需确保这些区域从成像到治疗及放疗全程中保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypoxia results from an imbalance between oxygen supply and consumption. It is a common phenomenon in solid malignant tumors such as head and neck cancer. As hypoxic cells are more resistant to therapy, tumor hypoxia is an indicator for poor prognosis. Several techniques have been developed to measure tissue oxygenation. These are the Eppendorf O2 polarographic needle electrode, immunohistochemical analysis of endogenous (e.g., hypoxia-inducible factor-1α (HIF-1a)) and exogenous markers (e.g., pimonidazole) as well as imaging methods such as functional magnetic resonance imaging (e.g., blood oxygen level dependent (BOLD) imaging, T1-weighted imaging) and hypoxia positron emission tomography (PET). Among the imaging modalities, only PET is sufficiently validated to detect hypoxia for clinical use. Hypoxia PET tracers include 18F-fluoromisonidazole (FMISO), the most commonly used hypoxic marker, 18F-flouroazomycin arabinoside (FAZA), 18Ffluoroerythronitroimidazole (FETNIM), 18F-2-nitroimidazolpentafluoropropylacetamide (EF5) and 18F-flortanidazole (HX4). As technical development provides the opportunity to increase the radiation dose to subregions of the tumor, such as hypoxic areas, it has to be ensured that these regions are stable not only from imaging to treatment but also through the course of radiotherapy. The aim of this review is therefore to characterize the behavior of tumor hypoxia during radiotherapy for the whole tumor and for subregions by using hypoxia PET tracers, with focus on head and neck cancer patients.
引用
- Stieb S, Eleftheriou A, Warnock G, et al. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy. Eur J Nucl Med Mol Imaging. 2018. PMID: 30128659. doi:10.1007/s00259-018-4116-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。